Last updated on: 25/06/2014
Name of organisation
1) Department/Research groupHealth Search
2) Organisation/affiliationItalian College of General Practicioners
Short Name in the inventoryHealth Search-SIMG
Administrative Contact
Title Mr
Last name Cricelli
First name Iacopo
Address line 1c/o Genomedics
Address line 2Via Sestese 61
Address line 3
CityFlorence
Postcode50141
CountryItaly
Phone number (incl. country code)39055494900
Alternative phone number
Fax number (incl. country code)
Scientific Contact
Title Dr
Last name Francesco
First name Lapi
Address line 1c/o SIMG
Address line 2Via del Pignoncino 9-11
Address line 3
CityFlorence
Postcode50142
CountryItaly
Phone number (incl. country code)+39055700027
Alternative phone number+393402648088
Fax number (incl. country code)
2. Description
The Italian College of General Practitioners (SIMG) is a scientific society aimed to promote the role of General Practice within the National Health System. The main activities are focused on education and research. Research is mainly developed throughout the Health Search network, based on: (1) a school in which primary care physicians (PCPs) receive training and shares the same standards for recording electronic patients information; (2) a database [Health Search/CSD longitudinal patients database (HSD)], where PCPs collects patients information. The group working with HSD data is a multidisciplinary team of epidemiologists, statisticians and IT experts; it provides value-added services to: (1) the PCPs who contribute to the HSD; (2) the stakeholders that are interested in using this research tool. Health Search-SIMG is currently involved in several national and multinational research projects on drug safety and drug utilization, HTA and health services research studies.
3. Category
Health Services Research Organization
4. Available resources
In houseVia Contacts/Network
Epidemiologist/Pharmacoepidemiologist
Yes
Yes
Statistician
Yes
Yes
Clinician
Yes
Yes
Clinical Pharmacologist
Yes
Yes
Pharmacist
Yes
Yes
Geneticist/Pharmacogeneticist
No
Yes
IT specialist
Yes
Yes
Ethics expertise
No
Yes
Legal expertise
No
Yes
Regulatory expertise
No
Yes
5. Therapeutic/disease areas of research in drug safety/risk-benefit performed in the past 5 years
Cardiovascular diseases
Disorders of the central nervous system
Endocrine disorders
Gastrointestinal tract
Geriatrics
Immunological products and vaccines
Infectious diseases
Liver disease
Musculoskeletal and joint diseases
Osteoporosis
Psychiatry
Renal impairment
Respiratory diseases
Skin disorders
Urinary tract disorders
6. Design of drug safety/risk-benefit studies published in the past 5 years
Cohort Study
Case Control Study
Drug Utilisation
Cross-sectional study
7. Experience in collecting data directly from individual patients/respondents
Number of Studies
Less than 5
Number of patients/respondents involved in the study(ies)
Between 150 and 1499
8. Access to data collection resources
Capacity to conduct face-to-face interviews
Yes
In a clinic
No
In the community
Yes
Electronic data capture systems
Yes
System used:
Delphi language, dotnet framework
Interactive voice response systems
No
Call centre
No
9. Experience in secondary research and meta-analysis
No
10. Work with existing data resources in the past 3 years
Name of data resourceNo. of studies
HSD15
11. Registries established by centre
Drug RegistryDrug prescription information (i.e. medication name, date of filled prescription, number of days' supply, dosage)
Disease RegistryDiagnoses [ICD9CM + free text]
Other Patient demographic details, drug prescription info, prevention records, specialist referrals, hospital admission, date of death
12. Experience in collaboration in a study team
Principal Investigator
Collaborating Investigator
13. Current involvement in research networks
Other networks:
Network nameNationalInternationalLink to webpage
14. Interest in research opportunities which are funded
By pharmaceutical companies
By charities
By government
By research councils
15. Interest in contract research only if free to publish results
Yes
16. Selected publications of the last 5 calendar years
ReferenceLink to web-publication
Trifirò G, Mokhles MM, Dieleman JP, van Soest EM, Verhamme K, Mazzaglia G, Herings R, de Luise C, Ross D, Brusselle G, Colao A, Haverkamp W, Schade R, van Camp G, Zanettini R, Sturkenboom MC. Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study. Drug Saf. 2012 Feb 1;35(2):159-71http://www.healthsearch.it/default2.asp?active_page_id=57
Lapi F, Simonetti M, Michieli R, Pasqua A, Brandi ML, Frediani B, Cricelli C, Mazzaglia G. Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care. Bone. 2012 Jan;50(1):85-90.
van Soest EM, Valkhoff VE, Mazzaglia G, Schade R, Molokhia M, Goldstein JL,
Hernández-Díaz S, Trifirò G, Dieleman JP, Kuipers EJ, Sturkenboom MC. Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases. Gut. 2011 Dec;60(12):1650-9.
Mazzaglia G, Filippi A, Alacqua M, Cowell W, Shakespeare A, Mantovani LG, Bianchi C, Cricelli C. A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care. Thromb Haemost. 2010 May 3;103(5):968-75
Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009 Oct 20;120(16):1598-605
